Skip to main content

Acquiring Expertise for Improved Patient Outcomes in Immune Thrombocytopenia

Recently, i3 Health provided an educational activity that has challenged knowledge gaps experienced by clinicians pertaining to the topic of improved patient outcomes in immune thrombocytopenia (ITP).   Immune thrombocytopenia is a heterogenous disorder in which patients develop an autoimmune response to platelets that results in severe cytopenia and places them at risk for bleeding events. The lack of specific criteria makes diagnosis challenging for clinicians, and understanding the patho...

Continue reading

Additional Advances in Immune Thrombocytopenia Research and Clinical Trials With Allison Imahiyerobo, APN

Oncology Data Advisor™ · Additional Advances in Immune Thrombocytopenia Research and Clinical Trials In 2022, Allison Imahiyerobo, an Advanced Practice Nurse at the Englewood Health Physician Network in New Jersey, led a continuing medical education (CME)/nursing continuing professional development (NCPD)–approved activity with i3 Health, New Insights and Avenues for Improved Patient Outcomes in Immune Thrombocytopenia. A year later, Ms. Imahiyerobo sat down with Oncology Data Advis...

Continue reading

Bridging Knowledge Gaps for Treatment of Immune Thrombocytopenia

i3 Health has provided an educational activity that has challenged knowledge gaps experienced by nursing staff regarding updated treatment options and optimal patient care for immune thrombocytopenia (ITP). ITP is an autoimmune platelet disorder in which the blood does not clot normally as a result of a low platelet count, causing bruising and bleeding. Research has shown that the burden of ITP is significant; in a survey of more than 1,300 patients from 13 different countries, 36% reported a hi...

Continue reading

Learning Needs in Immune Thrombocytopenia

Immune thrombocytopenia (ITP) is a heterogeneous disorder that involves a shortage of platelets, or thrombocytes, and can result in excessive bruising or bleeding. Diagnosis and treatment are challenging due to the lack of specific diagnostic criteria and the widely varying clinical features: some patients remain asymptomatic, whereas others experience troublesome bruising or even life-threatening intracranial hemorrhage. The optimal management of ITP necessitates an individualized approach that...

Continue reading